nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—Abiraterone—prostate cancer	0.249	0.401	CbGbCtD
Gatifloxacin—ALB—Estrone—prostate cancer	0.18	0.29	CbGbCtD
Gatifloxacin—ALB—Estradiol—prostate cancer	0.103	0.166	CbGbCtD
Gatifloxacin—ALB—Prednisone—prostate cancer	0.0887	0.143	CbGbCtD
Gatifloxacin—Moxifloxacin—TOP2A—prostate cancer	0.00133	0.149	CrCbGaD
Gatifloxacin—Pefloxacin—TOP2A—prostate cancer	0.000972	0.108	CrCbGaD
Gatifloxacin—Enoxacin—TOP2A—prostate cancer	0.000909	0.101	CrCbGaD
Gatifloxacin—Sparfloxacin—TOP2A—prostate cancer	0.000837	0.0933	CrCbGaD
Gatifloxacin—Lomefloxacin—TOP2A—prostate cancer	0.000689	0.0768	CrCbGaD
Gatifloxacin—Levofloxacin—TOP2A—prostate cancer	0.000589	0.0657	CrCbGaD
Gatifloxacin—Ofloxacin—TOP2A—prostate cancer	0.000589	0.0657	CrCbGaD
Gatifloxacin—Ciprofloxacin—TOP2A—prostate cancer	0.000569	0.0634	CrCbGaD
Gatifloxacin—Norfloxacin—TOP2A—prostate cancer	0.000478	0.0532	CrCbGaD
Gatifloxacin—Ciprofloxacin—CYP3A5—prostate cancer	0.000449	0.05	CrCbGaD
Gatifloxacin—Norfloxacin—CYP3A5—prostate cancer	0.000377	0.042	CrCbGaD
Gatifloxacin—Norfloxacin—CYP2A6—prostate cancer	0.000365	0.0407	CrCbGaD
Gatifloxacin—Norfloxacin—CYP1A1—prostate cancer	0.000256	0.0285	CrCbGaD
Gatifloxacin—Levofloxacin—CYP3A4—prostate cancer	0.000201	0.0224	CrCbGaD
Gatifloxacin—Ciprofloxacin—CYP3A4—prostate cancer	0.000194	0.0217	CrCbGaD
Gatifloxacin—Norfloxacin—CYP3A4—prostate cancer	0.000163	0.0182	CrCbGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	0.000104	0.00356	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—SERPINE1—prostate cancer	0.000103	0.00355	CbGpPWpGaD
Gatifloxacin—Hyperglycaemia—Doxorubicin—prostate cancer	0.000103	0.000302	CcSEcCtD
Gatifloxacin—Diarrhoea—Mitoxantrone—prostate cancer	0.000103	0.000302	CcSEcCtD
Gatifloxacin—Vomiting—Estradiol—prostate cancer	0.000103	0.000301	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Etoposide—prostate cancer	0.000103	0.0003	CcSEcCtD
Gatifloxacin—Shock—Docetaxel—prostate cancer	0.000102	0.0003	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Docetaxel—prostate cancer	0.000102	0.000298	CcSEcCtD
Gatifloxacin—Rash—Estradiol—prostate cancer	0.000102	0.000298	CcSEcCtD
Gatifloxacin—Dermatitis—Estradiol—prostate cancer	0.000102	0.000298	CcSEcCtD
Gatifloxacin—Confusional state—Capecitabine—prostate cancer	0.000102	0.000298	CcSEcCtD
Gatifloxacin—Tachycardia—Docetaxel—prostate cancer	0.000102	0.000298	CcSEcCtD
Gatifloxacin—Headache—Estradiol—prostate cancer	0.000101	0.000296	CcSEcCtD
Gatifloxacin—Agitation—Prednisone—prostate cancer	0.000101	0.000296	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000101	0.000296	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—ITGB3—prostate cancer	0.000101	0.00346	CbGpPWpGaD
Gatifloxacin—Oedema—Capecitabine—prostate cancer	0.000101	0.000295	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—ICAM1—prostate cancer	0.000101	0.00346	CbGpPWpGaD
Gatifloxacin—Bradycardia—Epirubicin—prostate cancer	0.000101	0.000295	CcSEcCtD
Gatifloxacin—Angioedema—Prednisone—prostate cancer	0.000101	0.000294	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CLU—prostate cancer	0.0001	0.00344	CbGpPWpGaD
Gatifloxacin—Infection—Capecitabine—prostate cancer	0.0001	0.000293	CcSEcCtD
Gatifloxacin—Urticaria—Etoposide—prostate cancer	9.96e-05	0.000291	CcSEcCtD
Gatifloxacin—Stomatitis—Doxorubicin—prostate cancer	9.94e-05	0.000291	CcSEcCtD
Gatifloxacin—Anorexia—Docetaxel—prostate cancer	9.93e-05	0.000291	CcSEcCtD
Gatifloxacin—Shock—Capecitabine—prostate cancer	9.92e-05	0.00029	CcSEcCtD
Gatifloxacin—Abdominal pain—Etoposide—prostate cancer	9.91e-05	0.00029	CcSEcCtD
Gatifloxacin—Body temperature increased—Etoposide—prostate cancer	9.91e-05	0.00029	CcSEcCtD
Gatifloxacin—Conjunctivitis—Doxorubicin—prostate cancer	9.91e-05	0.00029	CcSEcCtD
Gatifloxacin—Vertigo—Prednisone—prostate cancer	9.89e-05	0.000289	CcSEcCtD
Gatifloxacin—Hepatitis—Epirubicin—prostate cancer	9.89e-05	0.000289	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	9.88e-05	0.00339	CbGpPWpGaD
Gatifloxacin—Thrombocytopenia—Capecitabine—prostate cancer	9.88e-05	0.000289	CcSEcCtD
Gatifloxacin—Syncope—Prednisone—prostate cancer	9.87e-05	0.000289	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC7A1—prostate cancer	9.86e-05	0.00338	CbGpPWpGaD
Gatifloxacin—Tachycardia—Capecitabine—prostate cancer	9.84e-05	0.000288	CcSEcCtD
Gatifloxacin—Pharyngitis—Epirubicin—prostate cancer	9.82e-05	0.000287	CcSEcCtD
Gatifloxacin—Sweating—Doxorubicin—prostate cancer	9.77e-05	0.000286	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Capecitabine—prostate cancer	9.75e-05	0.000285	CcSEcCtD
Gatifloxacin—Oedema peripheral—Epirubicin—prostate cancer	9.74e-05	0.000285	CcSEcCtD
Gatifloxacin—Hypotension—Docetaxel—prostate cancer	9.73e-05	0.000285	CcSEcCtD
Gatifloxacin—Haematuria—Doxorubicin—prostate cancer	9.72e-05	0.000284	CcSEcCtD
Gatifloxacin—Loss of consciousness—Prednisone—prostate cancer	9.68e-05	0.000283	CcSEcCtD
Gatifloxacin—Epistaxis—Doxorubicin—prostate cancer	9.62e-05	0.000281	CcSEcCtD
Gatifloxacin—Anorexia—Capecitabine—prostate cancer	9.61e-05	0.000281	CcSEcCtD
Gatifloxacin—Nausea—Estradiol—prostate cancer	9.61e-05	0.000281	CcSEcCtD
Gatifloxacin—Vomiting—Mitoxantrone—prostate cancer	9.58e-05	0.00028	CcSEcCtD
Gatifloxacin—Convulsion—Prednisone—prostate cancer	9.54e-05	0.000279	CcSEcCtD
Gatifloxacin—Visual impairment—Epirubicin—prostate cancer	9.53e-05	0.000279	CcSEcCtD
Gatifloxacin—Hypertension—Prednisone—prostate cancer	9.5e-05	0.000278	CcSEcCtD
Gatifloxacin—Rash—Mitoxantrone—prostate cancer	9.5e-05	0.000278	CcSEcCtD
Gatifloxacin—Dermatitis—Mitoxantrone—prostate cancer	9.49e-05	0.000278	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Docetaxel—prostate cancer	9.49e-05	0.000278	CcSEcCtD
Gatifloxacin—Headache—Mitoxantrone—prostate cancer	9.44e-05	0.000276	CcSEcCtD
Gatifloxacin—Hypotension—Capecitabine—prostate cancer	9.42e-05	0.000276	CcSEcCtD
Gatifloxacin—Insomnia—Docetaxel—prostate cancer	9.42e-05	0.000276	CcSEcCtD
Gatifloxacin—Myalgia—Prednisone—prostate cancer	9.37e-05	0.000274	CcSEcCtD
Gatifloxacin—Arthralgia—Prednisone—prostate cancer	9.37e-05	0.000274	CcSEcCtD
Gatifloxacin—Paraesthesia—Docetaxel—prostate cancer	9.35e-05	0.000274	CcSEcCtD
Gatifloxacin—Erythema multiforme—Epirubicin—prostate cancer	9.35e-05	0.000274	CcSEcCtD
Gatifloxacin—Anxiety—Prednisone—prostate cancer	9.34e-05	0.000273	CcSEcCtD
Gatifloxacin—Bradycardia—Doxorubicin—prostate cancer	9.32e-05	0.000273	CcSEcCtD
Gatifloxacin—Dyspnoea—Docetaxel—prostate cancer	9.29e-05	0.000272	CcSEcCtD
Gatifloxacin—Somnolence—Docetaxel—prostate cancer	9.26e-05	0.000271	CcSEcCtD
Gatifloxacin—Eye disorder—Epirubicin—prostate cancer	9.24e-05	0.00027	CcSEcCtD
Gatifloxacin—Hypersensitivity—Etoposide—prostate cancer	9.24e-05	0.00027	CcSEcCtD
Gatifloxacin—Tinnitus—Epirubicin—prostate cancer	9.22e-05	0.00027	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Capecitabine—prostate cancer	9.19e-05	0.000269	CcSEcCtD
Gatifloxacin—Dyspepsia—Docetaxel—prostate cancer	9.17e-05	0.000268	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—INS—prostate cancer	9.16e-05	0.00314	CbGpPWpGaD
Gatifloxacin—Hepatitis—Doxorubicin—prostate cancer	9.15e-05	0.000268	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—MTHFR—prostate cancer	9.15e-05	0.00314	CbGpPWpGaD
Gatifloxacin—Insomnia—Capecitabine—prostate cancer	9.12e-05	0.000267	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—prostate cancer	9.08e-05	0.000266	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	9.06e-05	0.00311	CbGpPWpGaD
Gatifloxacin—Paraesthesia—Capecitabine—prostate cancer	9.06e-05	0.000265	CcSEcCtD
Gatifloxacin—Decreased appetite—Docetaxel—prostate cancer	9.06e-05	0.000265	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—prostate cancer	9.02e-05	0.000264	CcSEcCtD
Gatifloxacin—Asthenia—Etoposide—prostate cancer	8.99e-05	0.000263	CcSEcCtD
Gatifloxacin—Dyspnoea—Capecitabine—prostate cancer	8.99e-05	0.000263	CcSEcCtD
Gatifloxacin—Oedema—Prednisone—prostate cancer	8.98e-05	0.000263	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Prednisone—prostate cancer	8.98e-05	0.000263	CcSEcCtD
Gatifloxacin—Nausea—Mitoxantrone—prostate cancer	8.95e-05	0.000262	CcSEcCtD
Gatifloxacin—Infection—Prednisone—prostate cancer	8.93e-05	0.000261	CcSEcCtD
Gatifloxacin—Constipation—Docetaxel—prostate cancer	8.91e-05	0.000261	CcSEcCtD
Gatifloxacin—Dyspepsia—Capecitabine—prostate cancer	8.88e-05	0.00026	CcSEcCtD
Gatifloxacin—Chills—Epirubicin—prostate cancer	8.87e-05	0.00026	CcSEcCtD
Gatifloxacin—Pruritus—Etoposide—prostate cancer	8.87e-05	0.00026	CcSEcCtD
Gatifloxacin—Shock—Prednisone—prostate cancer	8.84e-05	0.000259	CcSEcCtD
Gatifloxacin—Visual impairment—Doxorubicin—prostate cancer	8.82e-05	0.000258	CcSEcCtD
Gatifloxacin—Tachycardia—Prednisone—prostate cancer	8.77e-05	0.000257	CcSEcCtD
Gatifloxacin—Decreased appetite—Capecitabine—prostate cancer	8.77e-05	0.000257	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—GNG5—prostate cancer	8.73e-05	0.003	CbGpPWpGaD
Gatifloxacin—Hyperhidrosis—Prednisone—prostate cancer	8.69e-05	0.000254	CcSEcCtD
Gatifloxacin—Erythema multiforme—Doxorubicin—prostate cancer	8.65e-05	0.000253	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—STX4—prostate cancer	8.63e-05	0.00296	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—RAD51B—prostate cancer	8.63e-05	0.00296	CbGpPWpGaD
Gatifloxacin—Constipation—Capecitabine—prostate cancer	8.63e-05	0.000252	CcSEcCtD
Gatifloxacin—Erythema—Epirubicin—prostate cancer	8.61e-05	0.000252	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	8.59e-05	0.00295	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	8.59e-05	0.00295	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	8.59e-05	0.00295	CbGpPWpGaD
Gatifloxacin—Feeling abnormal—Docetaxel—prostate cancer	8.58e-05	0.000251	CcSEcCtD
Gatifloxacin—Diarrhoea—Etoposide—prostate cancer	8.58e-05	0.000251	CcSEcCtD
Gatifloxacin—Anorexia—Prednisone—prostate cancer	8.56e-05	0.000251	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—prostate cancer	8.55e-05	0.00025	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—prostate cancer	8.53e-05	0.00025	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Docetaxel—prostate cancer	8.52e-05	0.000249	CcSEcCtD
Gatifloxacin—Flatulence—Epirubicin—prostate cancer	8.48e-05	0.000248	CcSEcCtD
Gatifloxacin—Tension—Epirubicin—prostate cancer	8.45e-05	0.000247	CcSEcCtD
Gatifloxacin—Dysgeusia—Epirubicin—prostate cancer	8.43e-05	0.000247	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—SERPINE1—prostate cancer	8.41e-05	0.00289	CbGpPWpGaD
Gatifloxacin—Nervousness—Epirubicin—prostate cancer	8.36e-05	0.000245	CcSEcCtD
Gatifloxacin—Back pain—Epirubicin—prostate cancer	8.33e-05	0.000244	CcSEcCtD
Gatifloxacin—Feeling abnormal—Capecitabine—prostate cancer	8.31e-05	0.000243	CcSEcCtD
Gatifloxacin—Dizziness—Etoposide—prostate cancer	8.29e-05	0.000243	CcSEcCtD
Gatifloxacin—Muscle spasms—Epirubicin—prostate cancer	8.28e-05	0.000242	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Capecitabine—prostate cancer	8.25e-05	0.000241	CcSEcCtD
Gatifloxacin—Abdominal pain—Docetaxel—prostate cancer	8.24e-05	0.000241	CcSEcCtD
Gatifloxacin—Body temperature increased—Docetaxel—prostate cancer	8.24e-05	0.000241	CcSEcCtD
Gatifloxacin—Chills—Doxorubicin—prostate cancer	8.21e-05	0.00024	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—EGF—prostate cancer	8.2e-05	0.00281	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	8.2e-05	0.00281	CbGpPWpGaD
Gatifloxacin—Musculoskeletal discomfort—Prednisone—prostate cancer	8.19e-05	0.00024	CcSEcCtD
Gatifloxacin—Insomnia—Prednisone—prostate cancer	8.13e-05	0.000238	CcSEcCtD
Gatifloxacin—Vision blurred—Epirubicin—prostate cancer	8.11e-05	0.000237	CcSEcCtD
Gatifloxacin—Paraesthesia—Prednisone—prostate cancer	8.07e-05	0.000236	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	8.06e-05	0.00277	CbGpPWpGaD
Gatifloxacin—Urticaria—Capecitabine—prostate cancer	8.01e-05	0.000234	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—ICAM1—prostate cancer	8e-05	0.00275	CbGpPWpGaD
Gatifloxacin—Body temperature increased—Capecitabine—prostate cancer	7.97e-05	0.000233	CcSEcCtD
Gatifloxacin—Abdominal pain—Capecitabine—prostate cancer	7.97e-05	0.000233	CcSEcCtD
Gatifloxacin—Vomiting—Etoposide—prostate cancer	7.97e-05	0.000233	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—prostate cancer	7.97e-05	0.000233	CcSEcCtD
Gatifloxacin—Agitation—Epirubicin—prostate cancer	7.91e-05	0.000232	CcSEcCtD
Gatifloxacin—Dyspepsia—Prednisone—prostate cancer	7.91e-05	0.000231	CcSEcCtD
Gatifloxacin—Rash—Etoposide—prostate cancer	7.9e-05	0.000231	CcSEcCtD
Gatifloxacin—Dermatitis—Etoposide—prostate cancer	7.9e-05	0.000231	CcSEcCtD
Gatifloxacin—Headache—Etoposide—prostate cancer	7.85e-05	0.00023	CcSEcCtD
Gatifloxacin—Flatulence—Doxorubicin—prostate cancer	7.85e-05	0.00023	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—prostate cancer	7.82e-05	0.000229	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—EGF—prostate cancer	7.81e-05	0.00268	CbGpPWpGaD
Gatifloxacin—Decreased appetite—Prednisone—prostate cancer	7.81e-05	0.000229	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—prostate cancer	7.8e-05	0.000228	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC39A1—prostate cancer	7.8e-05	0.00268	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—F9—prostate cancer	7.77e-05	0.00267	CbGpPWpGaD
Gatifloxacin—Nervousness—Doxorubicin—prostate cancer	7.74e-05	0.000226	CcSEcCtD
Gatifloxacin—Vertigo—Epirubicin—prostate cancer	7.74e-05	0.000226	CcSEcCtD
Gatifloxacin—Syncope—Epirubicin—prostate cancer	7.72e-05	0.000226	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—prostate cancer	7.71e-05	0.000225	CcSEcCtD
Gatifloxacin—Constipation—Prednisone—prostate cancer	7.68e-05	0.000225	CcSEcCtD
Gatifloxacin—Hypersensitivity—Docetaxel—prostate cancer	7.68e-05	0.000225	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—prostate cancer	7.66e-05	0.000224	CcSEcCtD
Gatifloxacin—Palpitations—Epirubicin—prostate cancer	7.61e-05	0.000223	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—IGF1—prostate cancer	7.6e-05	0.00261	CbGpPWpGaD
Gatifloxacin—Loss of consciousness—Epirubicin—prostate cancer	7.57e-05	0.000221	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—prostate cancer	7.51e-05	0.00022	CcSEcCtD
Gatifloxacin—Asthenia—Docetaxel—prostate cancer	7.47e-05	0.000219	CcSEcCtD
Gatifloxacin—Convulsion—Epirubicin—prostate cancer	7.46e-05	0.000218	CcSEcCtD
Gatifloxacin—Nausea—Etoposide—prostate cancer	7.45e-05	0.000218	CcSEcCtD
Gatifloxacin—Hypertension—Epirubicin—prostate cancer	7.43e-05	0.000218	CcSEcCtD
Gatifloxacin—Hypersensitivity—Capecitabine—prostate cancer	7.43e-05	0.000217	CcSEcCtD
Gatifloxacin—Feeling abnormal—Prednisone—prostate cancer	7.4e-05	0.000217	CcSEcCtD
Gatifloxacin—Pruritus—Docetaxel—prostate cancer	7.37e-05	0.000216	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Prednisone—prostate cancer	7.35e-05	0.000215	CcSEcCtD
Gatifloxacin—Arthralgia—Epirubicin—prostate cancer	7.33e-05	0.000214	CcSEcCtD
Gatifloxacin—Myalgia—Epirubicin—prostate cancer	7.33e-05	0.000214	CcSEcCtD
Gatifloxacin—Chest pain—Epirubicin—prostate cancer	7.33e-05	0.000214	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—prostate cancer	7.32e-05	0.000214	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	7.31e-05	0.00251	CbGpPWpGaD
Gatifloxacin—Anxiety—Epirubicin—prostate cancer	7.3e-05	0.000214	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—INS—prostate cancer	7.28e-05	0.0025	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—THBS1—prostate cancer	7.25e-05	0.00249	CbGpPWpGaD
Gatifloxacin—Asthenia—Capecitabine—prostate cancer	7.24e-05	0.000212	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—prostate cancer	7.24e-05	0.00248	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—SERPINE1—prostate cancer	7.21e-05	0.00248	CbGpPWpGaD
Gatifloxacin—Vertigo—Doxorubicin—prostate cancer	7.16e-05	0.000209	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—prostate cancer	7.14e-05	0.000209	CcSEcCtD
Gatifloxacin—Urticaria—Prednisone—prostate cancer	7.14e-05	0.000209	CcSEcCtD
Gatifloxacin—Pruritus—Capecitabine—prostate cancer	7.14e-05	0.000209	CcSEcCtD
Gatifloxacin—Diarrhoea—Docetaxel—prostate cancer	7.13e-05	0.000209	CcSEcCtD
Gatifloxacin—Body temperature increased—Prednisone—prostate cancer	7.1e-05	0.000208	CcSEcCtD
Gatifloxacin—Abdominal pain—Prednisone—prostate cancer	7.1e-05	0.000208	CcSEcCtD
Gatifloxacin—Confusional state—Epirubicin—prostate cancer	7.09e-05	0.000207	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—prostate cancer	7.04e-05	0.000206	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Epirubicin—prostate cancer	7.03e-05	0.000206	CcSEcCtD
Gatifloxacin—Oedema—Epirubicin—prostate cancer	7.03e-05	0.000206	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PRKCZ—prostate cancer	7.02e-05	0.00241	CbGpPWpGaD
Gatifloxacin—Loss of consciousness—Doxorubicin—prostate cancer	7e-05	0.000205	CcSEcCtD
Gatifloxacin—Infection—Epirubicin—prostate cancer	6.98e-05	0.000204	CcSEcCtD
Gatifloxacin—Shock—Epirubicin—prostate cancer	6.91e-05	0.000202	CcSEcCtD
Gatifloxacin—Convulsion—Doxorubicin—prostate cancer	6.9e-05	0.000202	CcSEcCtD
Gatifloxacin—Diarrhoea—Capecitabine—prostate cancer	6.9e-05	0.000202	CcSEcCtD
Gatifloxacin—Dizziness—Docetaxel—prostate cancer	6.89e-05	0.000202	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Epirubicin—prostate cancer	6.88e-05	0.000201	CcSEcCtD
Gatifloxacin—Hypertension—Doxorubicin—prostate cancer	6.88e-05	0.000201	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—prostate cancer	6.87e-05	0.00236	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	6.87e-05	0.00236	CbGpPWpGaD
Gatifloxacin—Tachycardia—Epirubicin—prostate cancer	6.86e-05	0.000201	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—IL2—prostate cancer	6.81e-05	0.00234	CbGpPWpGaD
Gatifloxacin—Hyperhidrosis—Epirubicin—prostate cancer	6.79e-05	0.000199	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—prostate cancer	6.78e-05	0.000198	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—prostate cancer	6.78e-05	0.000198	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—prostate cancer	6.78e-05	0.000198	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—prostate cancer	6.76e-05	0.000198	CcSEcCtD
Gatifloxacin—Anorexia—Epirubicin—prostate cancer	6.7e-05	0.000196	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—SERPINE1—prostate cancer	6.68e-05	0.00229	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	6.68e-05	0.00229	CbGpPWpGaD
Gatifloxacin—Dizziness—Capecitabine—prostate cancer	6.67e-05	0.000195	CcSEcCtD
Gatifloxacin—Vomiting—Docetaxel—prostate cancer	6.62e-05	0.000194	CcSEcCtD
Gatifloxacin—Hypersensitivity—Prednisone—prostate cancer	6.62e-05	0.000194	CcSEcCtD
Gatifloxacin—Rash—Docetaxel—prostate cancer	6.57e-05	0.000192	CcSEcCtD
Gatifloxacin—Hypotension—Epirubicin—prostate cancer	6.57e-05	0.000192	CcSEcCtD
Gatifloxacin—Dermatitis—Docetaxel—prostate cancer	6.56e-05	0.000192	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—prostate cancer	6.56e-05	0.000192	CcSEcCtD
Gatifloxacin—Headache—Docetaxel—prostate cancer	6.53e-05	0.000191	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	6.51e-05	0.00224	CbGpPWpGaD
Gatifloxacin—Oedema—Doxorubicin—prostate cancer	6.5e-05	0.00019	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—prostate cancer	6.5e-05	0.00019	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—prostate cancer	6.46e-05	0.000189	CcSEcCtD
Gatifloxacin—Asthenia—Prednisone—prostate cancer	6.45e-05	0.000189	CcSEcCtD
Gatifloxacin—Vomiting—Capecitabine—prostate cancer	6.41e-05	0.000188	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.4e-05	0.000187	CcSEcCtD
Gatifloxacin—Shock—Doxorubicin—prostate cancer	6.4e-05	0.000187	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Doxorubicin—prostate cancer	6.37e-05	0.000186	CcSEcCtD
Gatifloxacin—Rash—Capecitabine—prostate cancer	6.36e-05	0.000186	CcSEcCtD
Gatifloxacin—Pruritus—Prednisone—prostate cancer	6.36e-05	0.000186	CcSEcCtD
Gatifloxacin—Insomnia—Epirubicin—prostate cancer	6.36e-05	0.000186	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—CYP7B1—prostate cancer	6.35e-05	0.00218	CbGpPWpGaD
Gatifloxacin—Dermatitis—Capecitabine—prostate cancer	6.35e-05	0.000186	CcSEcCtD
Gatifloxacin—Tachycardia—Doxorubicin—prostate cancer	6.35e-05	0.000186	CcSEcCtD
Gatifloxacin—Headache—Capecitabine—prostate cancer	6.32e-05	0.000185	CcSEcCtD
Gatifloxacin—Paraesthesia—Epirubicin—prostate cancer	6.31e-05	0.000185	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—prostate cancer	6.29e-05	0.000184	CcSEcCtD
Gatifloxacin—Dyspnoea—Epirubicin—prostate cancer	6.26e-05	0.000183	CcSEcCtD
Gatifloxacin—Somnolence—Epirubicin—prostate cancer	6.25e-05	0.000183	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	6.21e-05	0.00213	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	6.21e-05	0.00213	CbGpPWpGaD
Gatifloxacin—Anorexia—Doxorubicin—prostate cancer	6.2e-05	0.000181	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC26A4—prostate cancer	6.19e-05	0.00213	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC12A2—prostate cancer	6.19e-05	0.00213	CbGpPWpGaD
Gatifloxacin—Nausea—Docetaxel—prostate cancer	6.19e-05	0.000181	CcSEcCtD
Gatifloxacin—Dyspepsia—Epirubicin—prostate cancer	6.19e-05	0.000181	CcSEcCtD
Gatifloxacin—Diarrhoea—Prednisone—prostate cancer	6.15e-05	0.00018	CcSEcCtD
Gatifloxacin—Decreased appetite—Epirubicin—prostate cancer	6.11e-05	0.000179	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—ITGA6—prostate cancer	6.08e-05	0.00209	CbGpPWpGaD
Gatifloxacin—Hypotension—Doxorubicin—prostate cancer	6.08e-05	0.000178	CcSEcCtD
Gatifloxacin—Constipation—Epirubicin—prostate cancer	6.01e-05	0.000176	CcSEcCtD
Gatifloxacin—Nausea—Capecitabine—prostate cancer	5.99e-05	0.000175	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PRKCQ—prostate cancer	5.97e-05	0.00205	CbGpPWpGaD
Gatifloxacin—Dizziness—Prednisone—prostate cancer	5.94e-05	0.000174	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.92e-05	0.000173	CcSEcCtD
Gatifloxacin—Insomnia—Doxorubicin—prostate cancer	5.88e-05	0.000172	CcSEcCtD
Gatifloxacin—ALB—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	5.88e-05	0.00202	CbGpPWpGaD
Gatifloxacin—Paraesthesia—Doxorubicin—prostate cancer	5.84e-05	0.000171	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—PTGS2—prostate cancer	5.84e-05	0.002	CbGpPWpGaD
Gatifloxacin—Dyspnoea—Doxorubicin—prostate cancer	5.8e-05	0.00017	CcSEcCtD
Gatifloxacin—Feeling abnormal—Epirubicin—prostate cancer	5.79e-05	0.000169	CcSEcCtD
Gatifloxacin—Somnolence—Doxorubicin—prostate cancer	5.78e-05	0.000169	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Epirubicin—prostate cancer	5.75e-05	0.000168	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—prostate cancer	5.72e-05	0.000167	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—CD9—prostate cancer	5.72e-05	0.00196	CbGpPWpGaD
Gatifloxacin—Vomiting—Prednisone—prostate cancer	5.71e-05	0.000167	CcSEcCtD
Gatifloxacin—ALB—Metabolism—HAO1—prostate cancer	5.67e-05	0.00194	CbGpPWpGaD
Gatifloxacin—Rash—Prednisone—prostate cancer	5.66e-05	0.000166	CcSEcCtD
Gatifloxacin—Dermatitis—Prednisone—prostate cancer	5.66e-05	0.000166	CcSEcCtD
Gatifloxacin—Decreased appetite—Doxorubicin—prostate cancer	5.65e-05	0.000165	CcSEcCtD
Gatifloxacin—Headache—Prednisone—prostate cancer	5.63e-05	0.000165	CcSEcCtD
Gatifloxacin—Urticaria—Epirubicin—prostate cancer	5.58e-05	0.000163	CcSEcCtD
Gatifloxacin—Constipation—Doxorubicin—prostate cancer	5.56e-05	0.000163	CcSEcCtD
Gatifloxacin—Body temperature increased—Epirubicin—prostate cancer	5.55e-05	0.000163	CcSEcCtD
Gatifloxacin—Abdominal pain—Epirubicin—prostate cancer	5.55e-05	0.000163	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—VAV3—prostate cancer	5.47e-05	0.00188	CbGpPWpGaD
Gatifloxacin—Feeling abnormal—Doxorubicin—prostate cancer	5.36e-05	0.000157	CcSEcCtD
Gatifloxacin—Nausea—Prednisone—prostate cancer	5.34e-05	0.000156	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—prostate cancer	5.32e-05	0.000156	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—ITPR1—prostate cancer	5.31e-05	0.00182	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	5.28e-05	0.00181	CbGpPWpGaD
Gatifloxacin—Hypersensitivity—Epirubicin—prostate cancer	5.18e-05	0.000151	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—CLU—prostate cancer	5.17e-05	0.00178	CbGpPWpGaD
Gatifloxacin—Urticaria—Doxorubicin—prostate cancer	5.16e-05	0.000151	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—prostate cancer	5.14e-05	0.00015	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—prostate cancer	5.14e-05	0.00015	CcSEcCtD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	5.11e-05	0.00175	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	5.06e-05	0.00174	CbGpPWpGaD
Gatifloxacin—Asthenia—Epirubicin—prostate cancer	5.04e-05	0.000148	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC22A3—prostate cancer	5.02e-05	0.00172	CbGpPWpGaD
Gatifloxacin—Pruritus—Epirubicin—prostate cancer	4.97e-05	0.000145	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—VEGFA—prostate cancer	4.96e-05	0.0017	CbGpPWpGaD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL6—prostate cancer	4.92e-05	0.00169	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	4.88e-05	0.00167	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Epirubicin—prostate cancer	4.81e-05	0.000141	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—prostate cancer	4.79e-05	0.00014	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—GRB7—prostate cancer	4.73e-05	0.00162	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—prostate cancer	4.73e-05	0.00162	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	4.71e-05	0.00162	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—ITGB3—prostate cancer	4.7e-05	0.00161	CbGpPWpGaD
Gatifloxacin—Asthenia—Doxorubicin—prostate cancer	4.66e-05	0.000136	CcSEcCtD
Gatifloxacin—Dizziness—Epirubicin—prostate cancer	4.65e-05	0.000136	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCG5—prostate cancer	4.64e-05	0.00159	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GRHL1—prostate cancer	4.62e-05	0.00159	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CBR1—prostate cancer	4.62e-05	0.00159	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ADI1—prostate cancer	4.62e-05	0.00159	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CSAD—prostate cancer	4.62e-05	0.00159	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TST—prostate cancer	4.62e-05	0.00159	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PSAT1—prostate cancer	4.62e-05	0.00159	CbGpPWpGaD
Gatifloxacin—Pruritus—Doxorubicin—prostate cancer	4.6e-05	0.000135	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—TGFB1—prostate cancer	4.55e-05	0.00156	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	4.51e-05	0.00155	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—GNG5—prostate cancer	4.5e-05	0.00154	CbGpPWpGaD
Gatifloxacin—Vomiting—Epirubicin—prostate cancer	4.47e-05	0.000131	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—prostate cancer	4.45e-05	0.00013	CcSEcCtD
Gatifloxacin—Rash—Epirubicin—prostate cancer	4.43e-05	0.00013	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	4.43e-05	0.00152	CbGpPWpGaD
Gatifloxacin—Dermatitis—Epirubicin—prostate cancer	4.43e-05	0.00013	CcSEcCtD
Gatifloxacin—Headache—Epirubicin—prostate cancer	4.4e-05	0.000129	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—TP53—prostate cancer	4.37e-05	0.0015	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—prostate cancer	4.34e-05	0.00149	CbGpPWpGaD
Gatifloxacin—Dizziness—Doxorubicin—prostate cancer	4.3e-05	0.000126	CcSEcCtD
Gatifloxacin—ALB—Metabolism—UGT2B15—prostate cancer	4.29e-05	0.00147	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GRHPR—prostate cancer	4.29e-05	0.00147	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CKMT2—prostate cancer	4.29e-05	0.00147	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—UGT2B17—prostate cancer	4.29e-05	0.00147	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	4.2e-05	0.00144	CbGpPWpGaD
Gatifloxacin—Nausea—Epirubicin—prostate cancer	4.17e-05	0.000122	CcSEcCtD
Gatifloxacin—Vomiting—Doxorubicin—prostate cancer	4.13e-05	0.000121	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—MED12—prostate cancer	4.13e-05	0.00142	CbGpPWpGaD
Gatifloxacin—Rash—Doxorubicin—prostate cancer	4.1e-05	0.00012	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—prostate cancer	4.1e-05	0.00012	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC22A1—prostate cancer	4.09e-05	0.00141	CbGpPWpGaD
Gatifloxacin—Headache—Doxorubicin—prostate cancer	4.07e-05	0.000119	CcSEcCtD
Gatifloxacin—ALB—Metabolism—RFK—prostate cancer	4.04e-05	0.00139	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PGAM2—prostate cancer	4.04e-05	0.00139	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NAGLU—prostate cancer	4.04e-05	0.00139	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MBTPS1—prostate cancer	4.04e-05	0.00139	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SULT2B1—prostate cancer	4.04e-05	0.00139	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTM3—prostate cancer	4.04e-05	0.00139	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AOX1—prostate cancer	4.04e-05	0.00139	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—IL6—prostate cancer	4e-05	0.00137	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	3.95e-05	0.00135	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—GNG5—prostate cancer	3.89e-05	0.00134	CbGpPWpGaD
Gatifloxacin—Nausea—Doxorubicin—prostate cancer	3.86e-05	0.000113	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—PRKACB—prostate cancer	3.84e-05	0.00132	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP3A43—prostate cancer	3.83e-05	0.00131	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AMACR—prostate cancer	3.83e-05	0.00131	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—DEGS1—prostate cancer	3.83e-05	0.00131	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NAT1—prostate cancer	3.83e-05	0.00131	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SRD5A2—prostate cancer	3.83e-05	0.00131	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	3.76e-05	0.00129	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	3.74e-05	0.00128	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—THBS1—prostate cancer	3.74e-05	0.00128	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CG—prostate cancer	3.68e-05	0.00126	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HSD17B1—prostate cancer	3.65e-05	0.00125	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	3.65e-05	0.00125	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—EGF—prostate cancer	3.64e-05	0.00125	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PRKCZ—prostate cancer	3.62e-05	0.00124	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.51e-05	0.0012	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.49e-05	0.0012	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.46e-05	0.00119	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IGF1—prostate cancer	3.37e-05	0.00116	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—PRKACB—prostate cancer	3.32e-05	0.00114	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	3.29e-05	0.00113	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HPGD—prostate cancer	3.25e-05	0.00112	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—B4GALT4—prostate cancer	3.25e-05	0.00112	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CD—prostate cancer	3.23e-05	0.00111	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SERPINE1—prostate cancer	3.2e-05	0.0011	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL6—prostate cancer	3.18e-05	0.00109	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.13e-05	0.00107	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PRKCQ—prostate cancer	3.08e-05	0.00106	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TNFRSF21—prostate cancer	3.06e-05	0.00105	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAUR—prostate cancer	3.04e-05	0.00104	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.99e-05	0.00103	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP7B1—prostate cancer	2.98e-05	0.00102	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTAP—prostate cancer	2.98e-05	0.00102	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—JAK2—prostate cancer	2.97e-05	0.00102	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.91e-05	0.000998	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SULT1E1—prostate cancer	2.9e-05	0.000995	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SRD5A1—prostate cancer	2.9e-05	0.000995	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—VAV3—prostate cancer	2.82e-05	0.000968	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	2.82e-05	0.000968	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.82e-05	0.000967	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.78e-05	0.000952	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HSD17B3—prostate cancer	2.77e-05	0.00095	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ACSL4—prostate cancer	2.77e-05	0.00095	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ITPR1—prostate cancer	2.74e-05	0.000939	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.73e-05	0.000939	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PHGDH—prostate cancer	2.65e-05	0.00091	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ARG2—prostate cancer	2.65e-05	0.00091	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—UMPS—prostate cancer	2.65e-05	0.00091	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.64e-05	0.000906	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.64e-05	0.000906	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LDHB—prostate cancer	2.6e-05	0.000893	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IL2—prostate cancer	2.59e-05	0.000889	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP3A5—prostate cancer	2.55e-05	0.000876	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—RXRA—prostate cancer	2.51e-05	0.000861	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PDHA1—prostate cancer	2.47e-05	0.000846	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—UCP3—prostate cancer	2.47e-05	0.000846	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TCN2—prostate cancer	2.47e-05	0.000846	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTA3—prostate cancer	2.47e-05	0.000846	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ITGB3—prostate cancer	2.42e-05	0.000831	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HSD3B1—prostate cancer	2.35e-05	0.000807	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC22A3—prostate cancer	2.35e-05	0.000807	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.28e-05	0.000783	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SRC—prostate cancer	2.26e-05	0.000775	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TBXAS1—prostate cancer	2.26e-05	0.000774	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTA4—prostate cancer	2.26e-05	0.000774	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.2e-05	0.000757	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	2.2e-05	0.000755	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTA2—prostate cancer	2.2e-05	0.000754	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCG5—prostate cancer	2.17e-05	0.000745	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SULT1A1—prostate cancer	2.17e-05	0.000745	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAU—prostate cancer	2.13e-05	0.000732	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTA1—prostate cancer	2.12e-05	0.000728	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTO1—prostate cancer	2.1e-05	0.00072	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HSD3B2—prostate cancer	2.1e-05	0.00072	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NAT2—prostate cancer	2.1e-05	0.00072	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CAV1—prostate cancer	2.08e-05	0.000715	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	2.02e-05	0.000693	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.02e-05	0.000692	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PLCB2—prostate cancer	2.01e-05	0.00069	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LRP2—prostate cancer	2.01e-05	0.00069	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP2C18—prostate cancer	2.01e-05	0.00069	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—P4HB—prostate cancer	1.97e-05	0.000677	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC22A1—prostate cancer	1.92e-05	0.000658	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	1.92e-05	0.000658	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CG—prostate cancer	1.9e-05	0.000651	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.9e-05	0.000651	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—EGF—prostate cancer	1.87e-05	0.000643	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SULT2A1—prostate cancer	1.87e-05	0.000641	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MED12—prostate cancer	1.84e-05	0.000631	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GNG5—prostate cancer	1.82e-05	0.000626	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CREBBP—prostate cancer	1.76e-05	0.000604	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NCOA3—prostate cancer	1.76e-05	0.000603	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IGF1—prostate cancer	1.74e-05	0.000596	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.73e-05	0.000593	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	1.72e-05	0.00059	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HPGDS—prostate cancer	1.68e-05	0.000575	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CD—prostate cancer	1.67e-05	0.000572	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP2C19—prostate cancer	1.67e-05	0.000572	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SERPINE1—prostate cancer	1.65e-05	0.000566	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTT1—prostate cancer	1.63e-05	0.000558	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ACHE—prostate cancer	1.63e-05	0.000558	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP2A6—prostate cancer	1.61e-05	0.000552	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.6e-05	0.000549	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS3—prostate cancer	1.57e-05	0.00054	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AKR1C3—prostate cancer	1.56e-05	0.000537	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PRKACB—prostate cancer	1.56e-05	0.000534	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP17A1—prostate cancer	1.54e-05	0.000528	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—JAK2—prostate cancer	1.53e-05	0.000525	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.52e-05	0.000522	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.52e-05	0.000521	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NCOA2—prostate cancer	1.47e-05	0.000503	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CB—prostate cancer	1.45e-05	0.000499	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.4e-05	0.000482	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC5A5—prostate cancer	1.4e-05	0.00048	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP2E1—prostate cancer	1.37e-05	0.000469	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NQO1—prostate cancer	1.35e-05	0.000464	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IL2—prostate cancer	1.33e-05	0.000458	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TH—prostate cancer	1.33e-05	0.000457	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.32e-05	0.000454	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP3A4—prostate cancer	1.32e-05	0.000452	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.31e-05	0.00045	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP1B1—prostate cancer	1.3e-05	0.000445	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GGT1—prostate cancer	1.25e-05	0.000431	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NCOA1—prostate cancer	1.24e-05	0.000424	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP19A1—prostate cancer	1.22e-05	0.000418	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—EP300—prostate cancer	1.2e-05	0.000411	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—RXRA—prostate cancer	1.18e-05	0.000403	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SRC—prostate cancer	1.16e-05	0.0004	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.14e-05	0.000392	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—VEGFA—prostate cancer	1.13e-05	0.000389	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—COMT—prostate cancer	1.13e-05	0.000389	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTP1—prostate cancer	1.13e-05	0.000387	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ITPR1—prostate cancer	1.11e-05	0.000381	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.09e-05	0.000374	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TYMS—prostate cancer	1.05e-05	0.00036	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TGFB1—prostate cancer	1.04e-05	0.000357	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTM1—prostate cancer	1.04e-05	0.000355	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LPL—prostate cancer	1.02e-05	0.000349	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP1A1—prostate cancer	9.82e-06	0.000337	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ERCC2—prostate cancer	9.74e-06	0.000334	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—KRAS—prostate cancer	9.64e-06	0.000331	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTHFR—prostate cancer	9.15e-06	0.000314	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPARA—prostate cancer	8.98e-06	0.000308	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CA—prostate cancer	8.86e-06	0.000304	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TP53—prostate cancer	8.57e-06	0.000294	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CAV1—prostate cancer	8.44e-06	0.00029	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.07e-06	0.000277	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CG—prostate cancer	7.69e-06	0.000264	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—INS—prostate cancer	7.28e-06	0.00025	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—AKT1—prostate cancer	7.24e-06	0.000248	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CREBBP—prostate cancer	7.13e-06	0.000245	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CD—prostate cancer	6.76e-06	0.000232	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NOS3—prostate cancer	6.38e-06	0.000219	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CB—prostate cancer	5.89e-06	0.000202	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTGS2—prostate cancer	5.84e-06	0.0002	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTEN—prostate cancer	5.09e-06	0.000175	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—EP300—prostate cancer	4.86e-06	0.000167	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CA—prostate cancer	3.59e-06	0.000123	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AKT1—prostate cancer	2.93e-06	0.000101	CbGpPWpGaD
